Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|Reporting of pharmacokinetics in case reports of haemodialysis patients.
|Full bibliographic reference||Gotta V, Dao K, Rodieux F, Buclin T, Livio F, Pfister M. Guidance to develop individual dose recommendations for patients on chronic hemodialysis. Expert Rev Clin Pharmacol. 2017;10(7):737-752.|
|Study design||Observational studies|
|Clinical area||Haematology, Pharmaceutical medicine, Renal medicine|
|Applies to the whole report or to individual sections of the report?||Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Procedure/Method, Results, Study characteristics (participants etc.)|
|Record last updated on||July 26, 2017|
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.